Mish Bioscience Pty Ltd · South Australia
A parent company for six businesses in bioscience, regulation and applied AI.
Mish Bioscience Pty Ltd owns and operates companies across ingredient supply, regulatory technology, consumer cosmetics, e-commerce software and applied artificial intelligence.
- Operating companies
- 6
- Ingredient categories
- 5
- Ingredients supplied
- 30
- Registered
- Australia
Group structure
One company, six operating businesses
Each business below is owned and operated by Mish Bioscience Pty Ltd. They share a company, a standard of documentation, and a view that claims should be evidenced.
Mish Bioscience Ingredients
Bulk ingredient supply, across five categories
Our ingredient company supplies manufacturers, contract packers and brand owners. Every line ships with a lot-specific Certificate of Analysis and full technical documentation.
Dairy Proteins
Whey and milk protein fractions for sports nutrition, clinical nutrition and food manufacturing.
View category →02Sports Nutrition & Amino Acids
Creatine, amino acids and performance actives for powders, capsules and ready-to-mix formats.
View category →03Vitamins & Minerals
Vitamin actives and mineral salts selected for stability and formulation compatibility.
View category →04Botanical & Herbal Extracts
Standardised plant extracts with defined marker compounds and assay methods.
View category →05Specialty & Functional
Probiotics, omega-3 powders, lactoferrin and other technically demanding actives.
View category →How the group operates
Four things that hold across every business
Evidence before assertion
Across every company in the group, a claim has to be traceable to something. It is why our regulatory business exists and why our ingredient business quotes against a specification rather than a price list.
Documentation as deliverable
Paperwork is not administration. In regulated supply chains it is what lets a quality team release material and a sponsor defend a finished product.
Regulated-industry literacy
Several of our companies serve markets governed by the Therapeutic Goods Act, cosmetic regulation or platform policy. That shapes how all of them are built.
Small, deliberate scope
Each business does a defined thing well rather than everything adequately. Where something is still in development, we say so plainly rather than marketing it early.